Medtronic Inc. (MDT): Today's Featured Health Services Winner

Medtronic was a winner within the health services industry, rising $0.88 (1.6%) to $54.40 on average volume
By TheStreet Wire ,

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic

(

MDT

) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.6%. By the end of trading, Medtronic rose $0.88 (1.6%) to $54.40 on average volume. Throughout the day, 5,053,860 shares of Medtronic exchanged hands as compared to its average daily volume of 5,058,500 shares. The stock ranged in a price between $53.92-$54.78 after having opened the day at $54.03 as compared to the previous trading day's close of $53.52. Other companies within the Health Services industry that increased today were:

Organovo Holdings

(

ONVO

), up 16.4%,

Bovie Medical Corporation

(

BVX

), up 11.4%,

BG Medicine

(

BGMD

), up 9.9% and

Synergetics USA

(

SURG

), up 9.0%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $54.1 billion and is part of the health care sector. Shares are up 30.5% year to date as of the close of trading on Tuesday. Currently there are 8 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates

Medtronic

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,

MiMedx Group

(

MDXG

), down 6.0%,

NeoGenomics

(

NEO

), down 3.6%,

Mazor Robotics

(

MZOR

), down 3.4% and

LipoScience

(

LPDX

), down 3.1% , were all laggards within the health services industry with

Aetna

(

AET

) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

Loading ...